Objective: Phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5-P ) is not only a precursor to inositol 1,4,5-trisphosphate (Ins 1,4,5-P ) 2 3
Introduction
as the Na / Ca exchange and Ca -pump activities [2, 3] . In addition, PtdIns 4,5-P is a precursor of second 2 Phosphatidylinositol 4,5 bisphosphate (PtdIns 4,5-P ) messengers (see below) and is a distinct signalling mole-2 directly regulates diverse bioprocesses occurring at the cule per se [4, 5] in that it serves as a membrane attachment cardiac cell membrane (sarcolemma, SL) as, for example, site and activity regulator for important signalling-related 1 the function of the inward rectifier K channels [1] as well proteins containing pleckstrin-homology domains [6] . Notable examples of these proteins are protein kinases such as b-adrenoceptor kinase, phospholipase D1, cytosolic phosq Presented in part at the 43rd Annual Meeting of the Biophysical pholipase A and phosphoinositide-phospholipase C d CHF secondary to large transmural myocardial infarcts in 0.25 M sucrose, 10 mM histidine (pH 7.4), frozen in (MI) in rats [11] . These abnormalities could have a liquid N and stored at 2808C until assayed. Marker 2 relevant impact on the complex PtdIns 4,5-P -related enzymes were assessed in this SL preparation (n54). In 2 signalling and may constitute an important mechanism particular, the relative specific activity (specific activity in 1 underlying the defective cardiac performance in CHF. SL / specific activity in homogenate) of K -p-nitrophenol Thus, we conducted the present study on an etiologically phosphatase (SL marker) was similar in control and different model of CHF i.e. the UM-X7.1 subline of cardiomyopathic hamster (CMPH) preparations (9.260.8 cardiomyopathic hamster at the age of 250 days, when the and 8.660.6 in control and CMPH, respectively). This animals are in overt CHF [12] . The aim of our study was indicated an equal degree of enrichment of the SL memto verify the possibility that the dysfunction of SL PtdIns brane in control and experimental preparations. The rela-4,5-P and of its synthesis and hydrolysis already observed tive specific activity of rotenenone-insensitive NADPH-2 in post-MI CHF [11] , could also occur in the failing cytochrome C reductase (SR marker) was 0.4960.07 and cardiomyopathic hamster, which would suggest that these 0.5460.08 and that of cytochrome c oxidase (mitochondefects are intrinsic to the state of ventricular failure in drial marker) was 0.6360.06 and 0.6860.07 in control and CHF.
CMPH preparations. These results appear to indicate that the SL fractions under study were relatively pure and had only a minimal, but equal amount of, contamination from 2. Methods other subcellular organelles.
All the above steps were carried out at 0-48C. Protein 2.1. Experimental model concentrations were determined by the Lowry method as indicated elsewhere [11] . Male UM-X7.1 cardiomyopathic hamsters at the age of 250 days (from the laboratory of Dr. G. Jasmin, Department of Pathology, University of Montreal, Canada) were 2.3. PtdIns 4 kinase and PtdIns 4-phosphate 5 kinase employed in this study as a model of congestive heart assay failure [13] . UM-X7.1 is a cardiomyopathic subline of the Syrian Golden hamster [14] [15] [16] . Thus, as in past studies
The activities of PtdIns 4 kinase and PtdIns 4-phosphate [12, [16] [17] [18] , age-matched, healthy Syrian Golden hamsters 5 kinase were assayed as described previously [11] . later by adding methanol-10 M HCl (100:1, v / v) followed ventricular tissue from three to five hearts was pooled to by the addition of 2.5 M HCl and chloroform. After prepare cytosolic and SL fractions according to the method centrifugation, the aqueous phase was discarded and the of Pitts [19] as previously described [11] . The tissue was organic phase was washed once with chloroform-methawashed, minced and homogenized in 3.5 ml of buffer A / g nol-0.6 M HCl (3:48:47, v /v/v). Aliquots of the comtissue with a Polytron (6310 s, setting 5). Large cellular bined organic phases were used for the analysis of particles were removed by centrifugation at 12 000 g (30 phosphoinositides by thin-layer chromatography. The solmin, 48C). A small aliquot of the first supernatant was vent for the separation of phosphoinositide species concentrifuged at 110 000 g (60 min, 48C), and the resulting tained chloroform-acetone-methanol-glacial acetic acidsupernatant was frozen and stored (2808C) as the soluble water (40:15:13:12:8, v / v). The phospholipid migration cytosolic fraction. The rest of the first supernatant was was monitored using authentic unlabelled PtdIns 4-P and 32 diluted with 300 mM KCl-buffer to solubilize myofibrillar PtdIns 4,5-P phospholipid standards. The P-labeled 2 proteins [20] , and further processed for the preparation of phospholipid spots were visualized by overnight au-SL according to the method used previously [11] as shown toradiography using X-Omat-R X-ray film. PtdIns 4-P and in Fig. 1 . The resultant SL-enriched pellet was resuspended PtdIns 4,5-P were scraped from the plates and the results reported here, some experiments in which the SL The reactions were terminated after 2.5 min by the addition membrane fractionation as well as the phosophorylation of 144 ml ice-cold chloroform-methanol-HCl (1:2:0.2, assay were carried out in the presence of inhibitors of v / v) followed by 48 ml of 2 M KCl and 48 ml chloroform. phosphatase activity (10 nM microcystin-LR and 10 nM Blanks were carried out under identical conditions except sodium pyrophosphate) [21] . However, the results in the that protein was added after the reaction was stopped. presence of phosphatase inhibitors were similar to those Phase separation was facilitated by mixing and centrifugareported here; this indicated that changes in phosphatase tion, and the resulting aqueous phase was aspirated and activity in the CMPH heart did not influence the results applied to a 500-ml Dowex AG1-X8 microcolumn (forreported here.
mate form, 100-200 mesh). After the column was rinsed with water and with borax in sodium formate, inositol 2.4. Total phospholipase C assay mono-, bis-and trisphosphates were eluted each with 1 ml of 0.1 M formic acid containing 0.2, 0.4 and 1 M The total PLC activity associated with the SL membrane ammonium formate, respectively. The radioactivity in each was determined as previously reported [11, 22] . Briefly, the eluate was quantitated by liquid scintillation counting in 10 captured by adding 100 ml of washed protein G Sepharose bead slurry (50 ml packed beads) at 48C by rotation for 2 h.
Western blot of PLC isoenzymes
The agarose beads were collected by pulse centrifugation (5 s) at 10 000 g and assayed for the activity of PLC High-molecular-weight markers (Bio-Rad, Hercules, isoenzymes as described previously [11] . Briefly, the CA, USA) and 20 mg of SL or cytosolic proteins were reaction was performed in the presence of 30 mM HEPES, separated on sodium dodecyl sulfate-polyacrylamide gel pH 6.8, 70 mM KCl, 100 mM NaCl, 0.8 mM EGTA, 0.8 electrophoresis (SDS-PAGE probed with primary PLC isoenzyme antibodies. Primary The reaction was carried out at 378C for 2.5 min, after antibodies were diluted in TBS-T (1:2000). Horseradish which it was stopped by trichloroacetic acid precipitation.
peroxidase (HRP)-labeled anti-rabbit IgG (Bio-Rad) was Precipitates were removed by centrifugation at 10 000 g diluted 1:3000 in TBS-T and used as secondary antibody. for 5 min, and the supernatant was collected for quantificaPLCb , g and d were visualized by enhanced chemi-
tion of inositol phosphates by liquid scintillation counting. luminescence (ECL) according to the manufacturer's inThe efficiency of the immunoprecipitation of each isostructions (Boehringer Mannheim, Laval, Quebec, enzyme was ascertained by determining any residual PLC Canada). Band intensities of the Western blot were quanisoenzyme activity in the 10 000 g supernatant after tified using a CCD camera imaging densitometer (Bio-Rad capturing the immunocomplex by Protein G Sepharose.
GS 670). The supernatant was concentrated to 100 ml by using microconcentrators (Centricon-3, Amicon Canada, Oak-2.8. Statistical analysis ville, Canada) and then tested for PLC isoenzyme activities. The immunoprecipitation was complete, as PLCAll values are expressed as mean6SEM. The differ- precipitated isoenzyme could not be detected in the t-test. A probability of 95% or more (P,0.05) was concentrated supernatant. In fact, no activity was detectconsidered significant. able after subjecting this supernatant to a further immunoprecipitation with each specific antibody. For control experiments, immunoprecipitation and subsequent activity 3. Results measurements were conducted with non-immune mouse IgG.
3.1. General characteristics of the experimental animals Although the activities of each PLC isoenzyme have been measured basically according to the procedure estab-
The heart underwent a significant increase in mass as lished by Wahl et al. [26] , it should be pointed out that the indicated by an increase in the ventricular weight and by activities of these isoenzymes as reported here represent the augmented ratio of ventricular weight to body weight the relative activities since the antibodies used for imcompared to control values. The presence of ascites in munoprecipitation are known to inhibit the PLC isoenzyme CMPH indicated the occurrence of congestive heart failure activities [24, 25] . Furthermore, only a small proportion of in these animals ( Table 1) . 
Sarcolemmal phosphoinositide kinase and total phospholipase C activities
The activities of PtdIns 4 kinase and PtdIns 4-phosphate 5 kinase were significantly depressed in the failing heart as compared to control ( Fig. 2A and B) . Of note, the activity of PtdIns 4-kinase, which is considered as the rate-limiting activity was also observed in the failing heart (Fig. 3) . 2 to five experiments and are expressed as nmol of total inositol phosphates (InsPs) formed / mg SL protein / min. *, P,0.05 vs. control.
Sarcolemmal PLC isoenzyme protein content and activities
The rank order of the PLC isoenzymes' catalytic activities towards PtdIns 4,5-P was PLCg .PLCb .PLCd displays a form of hypertrophic cardiomyopathy [16] resembling that occurring in humans [12, 29] and constitutes a good model of naturally occurring congestive heart failure [13] . In the present pathophysiological study, we have investigated the sarcolemmal PtdIns 4,5-P level, PtdIns precursor, which is the substrate for PtdIns 4 kinase, has to be maintained at a certain level in the membrane.
We have shown an increase in the SL content of PtdIns in this model of heart failure [17] . This would imply that the translocation of newly synthesized PtdIns from sarcoplasmic reticulum to the plasma membrane by the cytosolic PtdIns-transfer protein is normal [30, 31] . Therefore, it is plausible that the severe reduction of PtdIns 4 kinase activity, the rate-limiting step in PtdIns 4,5-P biosynthetic 2 pathway, is one of the key defects responsible for the drastic deficit of PtdIns 4,5-P in the SL membrane of the 2 failing CMPH heart. The potential functional relevance of the observed a cofactor [39] . Although the specific role played by each reported by others in the case of human heart trans-PLD isoenzyme in cardiac cell function is still undefined, glutaminase II [42] . It may be possible that the carPLDs' importance is shown by our studies that relate their diomyopathy had induced defects in the protein structure hydrolysis product, phosphatidic acid, to the increase in of the PLC isoenzymes, and this could have affected their 21 intracellular Ca and cardiac performance [40] , and by catalytic activity and / or their binding to the substrate. the possible involvement of SL PLD2 in the reorganization Alterations of the physicochemical characteristics of the of the actin cytoskeleton [41] .
membrane environment of the isoenzymes may have also In post-infarct CHF we found overabundance and contributed to the discrepancies between the mass and hyperactivity of the SL PLCb with a drastic reduction of activity of SL PLCb and g [17, 28] . Specific studies 1 1 levels did not correlate with the measured activities. post-infarct CHF [11] , this pathway may not serve as a Discrepancies between protein mass and activity were source of positive inotropy to compensate the defective already observed by us in the case of SL PLCs [11] and b-adrenergic response seen in the genetic cardiomyopathy model of CHF [38] . However, only a detailed examination of all components Table 2 of the pathway and of the inotropic response to a - 
